A note about the resource

About

Cedar Current is an independent resource built for people who need a steadier way to approach uncertain health information.

01 — Why we exist

A place to slow down.

Cedar Current helps people understand the emerging, uncertain evidence around ibogaine and Parkinson’s disease. It offers clear context on research, safety, policy, and unanswered questions without overstating potential benefits.

The resource exists for people with Parkinson’s disease, care partners, and others seeking grounded context on ibogaine-related research and risks. The main Cedar Current resource is organized to make the questions, limits, and practical context easier to locate without asking readers to accept stronger conclusions than the evidence supports.

Our aim is not to direct anyone toward a treatment decision. It is to make room for careful reading, useful questions, and conversations with qualified professionals.

02 — Our editorial approach

Evidence before certainty.

We look to research registries, published literature, official sources, and source material that can be checked. A registry record can show what is being studied and how a study is described; the ClinicalTrials.gov study registry is one example of a public record readers can examine directly.

We distinguish between an early signal, a reported experience, a hypothesis, and an established finding. That distinction matters because a source’s format and limits shape what it can responsibly support.

Our guides and ways Cedar Current organizes information are built around that same restraint: explain what is available, identify what remains unknown, and avoid turning uncertainty into a promise.

Working principles

What guides the work

Evidence before claims. We keep the strength of the language aligned with the strength of the source.
Clear uncertainty. We name gaps rather than filling them with inference.
Safety awareness. We keep risk and practical constraints visible, not peripheral.
Plain language. We make sources easier to navigate without simplifying away their limits.
Independence. We are an information resource, not a treatment provider.

03 — Who this is for

For the person holding the question.

“A careful resource should make it easier to see both what a source says and what it cannot yet say.”

The standard Cedar Current aims to meet

People often arrive with limited time, high stakes, and a great deal to sort through. Cedar Current is intended to support a more deliberate next step: reviewing information, recognizing uncertainty, and bringing better questions to clinicians, care teams, or other qualified professionals.

04 — What we cover

A clear path through the material.

Information is arranged so readers can move from broad orientation to more specific questions without losing sight of safety, evidence quality, and unanswered issues.

When technical language needs context, we point to durable reference material where appropriate. For example, the NCBI Bookshelf collection provides access to scientific and medical reference texts that can help readers assess terminology in context.

Orientation
Start with scope.
Plain-language pages establish what a question is asking, what sources are available, and where the limits begin.
Evidence
Follow the source trail.
Research records, literature, and official material are considered in their original context, not as isolated headlines or conclusions.
Context
Keep risk in view.
Safety, policy, and unanswered questions remain part of the same conversation as potential interest or emerging research.
Next questions
Make room for judgment.
Resources are designed to help readers identify what they may need to discuss with qualified professionals, rather than supplying personal medical or legal direction.

05 — Independent by design

Context, not a course of treatment.

Cedar Current is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and it does not provide medical or legal advice. Its content should not replace guidance from qualified professionals. Public health information from sources such as the U.S. Food and Drug Administration’s drug information can help readers understand why official oversight and professional guidance belong in high-stakes health decisions.

For readers comparing broader questions about brain health and aging, the independent context available at ibogaine brain aging can sit alongside material on ibogaine brain de-aging, while other topic-specific resources discuss ibogaine and ALS, ibogaine and Alzheimer’s disease, and ibogaine-related dementia questions. Each should be approached with the same attention to source quality, uncertainty, and safety.

Begin with the research primer